CASODEX

This brand name is authorized in United States. It is also authorized in Austria, Brazil, Canada, Croatia, Cyprus, Ecuador, Estonia, Finland, France, Germany, Hong Kong SAR China, Ireland, Israel, Italy, Japan, Lithuania, Mexico, Netherlands, Nigeria, Romania, Singapore, South Africa, Spain, Tunisia, Turkey, UK.

Active ingredients

The drug CASODEX contains one active pharmaceutical ingredient (API):

1	Bicalutamide UNII A0Z3NAU9DP - BICALUTAMIDE
	Bicalutamide is a non-steroidal antiandrogen, devoid of other endocrine activity. It binds to androgen receptors without activating gene expression, and thus inhibits the androgen stimulus. Regression of prostatic tumours results from this inhibition.
	Read more about Bicalutamide

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
CASODEX Film-coated tablets	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
L02BB03	Bicalutamide	L Antineoplastic and immunomodulating agents → L02 Endocrine therapy → L02B Hormone antagonists and related agents → L02BB Anti-androgens
Discover more medicines within L02BB03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
BR	Câmara de Regulação do Mercado de Medicamentos	502301101114318
CA	Health Products and Food Branch	02184478
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	01170365, 01170371, 01262848, 02805446, 05968143, 05968166, 06799754, 07433133, 07465452
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	640-MEE-0115
EE	Ravimiamet	1012194, 1026560
ES	Centro de información online de medicamentos de la AEMPS	61055, 71927
FI	Lääkealan turvallisuus- ja kehittämiskeskus	123242, 123253
FR	Base de données publique des médicaments	67949737
GB	Medicines & Healthcare Products Regulatory Agency	138470, 143466, 143467, 161468, 186251, 198673, 20823, 20826, 373498, 373517
HK	Department of Health Drug Office	41794, 49624
HR	Agencija za lijekove i medicinske proizvode	HR-H-423625979, HR-H-959901547
IE	Health Products Regulatory Authority	88020, 88021, 88439, 88592
IL	מִשְׂרַד הַבְּרִיאוּת	3703
IT	Agenzia del Farmaco	031113018, 031113020
JP	医薬品医療機器総合機構	4291009F1039, 4291009F2027
LT	Valstybinė vaistų kontrolės tarnyba	1002118, 1003622
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	071M97
NG	Registered Drug Product Database	04-2737, B4-0036
Switch country to Nigeria in order to find specific presentations of CASODEX
NL	Z-Index G-Standaard, PRK	42005
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W68106001, W68107001
SG	Health Sciences Authority	09772P, 11344P
TN	Direction de la Pharmacie et du Médicament	4833011
TR	İlaç ve Tıbbi Cihaz Kurumu	8699586094286, 8699586094293
US	FDA, National Drug Code	62559-680
ZA	Health Products Regulatory Authority	30/21.12/0012, 33/21.12/0081